Atara Biotherapeutics

ATRANasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$89.637 M

$8.93 -4.80%

Close of 22 Sept 2026

Revenue

$120.8M

#2447 by revenue

Earnings

$32.7M

#1722 by earnings

Shares outstanding

10,037,710

Latest filing cover page

P/E ratio

2.7

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#113Cardiff OncologyCRDF$103.5M
#114Cognition TherapeuticsCGTX$93.3M
#115Atara BiotherapeuticsATRA$89.6M
#116Pelthos TherapeuticsPTHS$89.0M
#117Greenland MinesGRML$82.8M

What if Atara Biotherapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$3,012,039

Per share 337,294× higher

Bitcoin $1.74T

$173,511.19

Per share 19,430× higher

Nvidia $5.52T

$549,504.52

Per share 61,535× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Atara Biotherapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.